ALARA in practice-4 decades of radiological protection at Goesgen NPP.

ALARA LNT justification low doses optimisation radiation exposure

Journal

Journal of radiological protection : official journal of the Society for Radiological Protection
ISSN: 1361-6498
Titre abrégé: J Radiol Prot
Pays: England
ID NLM: 8809257

Informations de publication

Date de publication:
27 Sep 2021
Historique:
received: 29 05 2021
accepted: 04 08 2021
pubmed: 5 8 2021
medline: 25 11 2021
entrez: 4 8 2021
Statut: epublish

Résumé

This paper provides an overview of results achieved through a whole set of ALARA investigations at the Goesgen Nuclear Power Plant. Doses to workers, the public and the environment have significantly dropped in recent years. Even the doses to the most exposed workers at the plant are not bigger than doses from natural background radiation. Recent reviews of epidemiological data call attention to the importance of recognising that the risk of cancer at low doses is small and might contribute only a very small, non-detectable fraction to an individual's overall risk. Based on the global cultural change on how society is facing any kind of risk, the initial ALARA philosophy is moving more and more to a continuing expectation that optimisation is equivalent to reduction. This philosophy change is even more pronounced in the light of the ongoing discussions about the effects of low dose radiation. Multiple conservatisms in dose models and dose calculations will lead to an imbalance between radiation risks and benefits. Overweighting radiation risks from low doses causes anxiety among the public and unnecessary economic burden to nuclear facilities. In light of pressing global issues (i.e. climate change), a discussion about the meaning of the 'R' in ALARA is recommended.

Identifiants

pubmed: 34348243
doi: 10.1088/1361-6498/ac1a82
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2021 Society for Radiological Protection. Published on behalf of SRP by IOP Publishing Limited. All rights reserved.

Auteurs

Marcel Lips (M)

Goesgen Nuclear Power Plant, P.O. Box, CH-4658 Daeniken, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH